Gallbladder Cancer: Epidemiological, Clinical, Therapeutic and Prognostic Aspects - A Case Series: Case Report

Hajri Amal; Benzidane Kamal; Zalarh Fadoua; Benjelloun Touimi Kenza; El Wassi Anas; Erguibi Driss; Boufettal Rachid; Rifki Jai Saad

doi:10.58372/2835-6276.1391

Authors

Hajri Amal
Benzidane Kamal
Zalarh Fadoua
Benjelloun Touimi Kenza
El Wassi Anas
Erguibi Driss
Boufettal Rachid
Rifki Jai Saad

DOI:

https://doi.org/10.58372/2835-6276.1391

Abstract

Gallbladder cancer is a rare malignancy with a poor prognosis, often diagnosed at an advanced stage. This retrospective study included 49 cases managed at Ibn Rochd University Hospital in Casablanca between 2012 and 2020, with a female predominance and a mean age of 61 years.

The most common clinical features were right upper quadrant pain, weight loss, and vomiting. Diagnosis was based on imaging and histopathological examination, sometimes incidentally after cholecystectomy.

Curative surgery was possible in only a minority of patients, while most received palliative treatment. The median survival was 8 months.

Gallbladder cancer remains a highly aggressive disease, highlighting the need for early diagnosis and multidisciplinary management.

References

Mikayla A. Schmidt, Lorena Marcano-Bonilla, Lewis R. Roberts. Gallbladder cancer: epidemiology and genetic risk associations. Chinese Clinical Oncology. 2019.

Robert W. Krell, Alice C. Wei. Gallbladder cancer: surgical management. Chinese Clinical Oncology. 2019.

M. Rajgopal Acharya, Shraddha Patkar, Amir Parray, Mahesh Goel. Management of gallbladder cancer in India. Chinese Clinical Oncology. 2019.

Milind Javle, Haitao Zhao, Ghassan K. Abou-Alfa. Systemic therapy for gallbladder cancer. Chinese Clinical Oncology. 2019.

Rajveer Hundal, Eldon A Shaffer. Gallbladder cancer: epidemiology and outcome. Clinical Epidemiology. 2014.

Tashiro Seiki, Imaizumi T, Ohkawa H, et al. Pancreaticobiliary maljunction: Retrospective and nationwide survey in Japan. Journal of Hepato‐Biliary‐Pancreatic Surgery. 10, 2003, Vol. 5, pp. 345-351.

Laura Hickman, Carlo Contreras. Gallbladder Cancer ; Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin N Am. 99, 2019, pp. 337–355.

S. Gourgiotis, H.M. Kocher et al. Gallblader cancer. The American Journal of Surgery () ,. 196, 2008, pp. 252–264.

BARTLETT, DAVID L. Gallblader cancer. Seminars in Surgical Oncology ; :. 19, 2000, pp. 145–155.

Chaube A, Tewari M, Singh U, et al. CA 125: a potential tumour marker for gallbladder cancer. J Surg Oncol . 93, 2006, pp. 665–9.

Gupta, P., Meghashyam, K., Marodia, Y. et al. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol. 2021, Vol. 46, pp. 998–1007.

Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol. 94, 2020.

M. Rakić, L. Patrlj, M. Kopljar et al. Gallbladder cancer. Hepatobiliary Surg Nutr. 3, 2014, Vol. 5, pp. 221-226.

M. Rajgopal Acharya, Shraddha Patkar, Amir Parray, Mahesh Goel. Management of gallbladder cancer in India. Chin Clin Oncol ;():. 8, 2019, Vol. 4, 35 .

Kim SJ, Lee JM, Lee ES, Han JK, Choi BI, et al. Preoperative staging of gallbladder carcinoma using biliary MR imaging: biliary MRI to determine laparoscopic or open surgery. J Magn Reson Imaging . 41, 2015.

Schwartz LH, Black J, Fong Y, Jarnagin W, Blumgart L, Gruen D, et al. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography. J Comput Assist Tomogr . 26, 2002, pp. 405-10.

Jacobson BC, Pitman MB, Brugge WR. EUS- guided fna for the diagnosis of gallbladder masses. Gastrointest Endosc . 57, 2003, pp. 251–4.

Varadarajulu S, Eloubeidi MA. Endoscopic ultrasound- guided fine- needle aspiration in the evaluation of gallbladder masses. Endoscopy. 37, 2005, pp. 751–4.

Xiaoling Song, Yunping Hu, Yongsheng L, et al. Overview of current targeted therapy in gallbladder cancer. Signal Transduction and Targeted Therapy. 5, 2020, Vol. 230.

Joo I, Lee JY, Kim JH, et al. Differentiation of adenomyomatosis of the gallbladder from early-stage, wallthickening-type gallbladder cancer using high-resolution ultrasound. Eur Radiol. 23, 2013, pp. 730-8.

Cho JY, Han HS, Yoon YS, Ahn KS, Kim YH, Lee KH. Laparoscopic approach for suspected early-stage gallbladder carcinoma. Arch Surg. 145, 2010, pp. 128–133.

Palanisamy S, Patel N, Sabnis S, Palanisamy N, Vijay A, Palanivelu P, Parthasarthi R, Chinnusamy P. Laparoscopic radical cholecystectomy for suspected early gallbladder carcinoma: thinking beyond convention. Surg Endosc. 30, 2016, pp. 2442–2448.

Yoon YS, Han HS, Cho JY, Choi Y, Lee W, Jang JY, Choi H. Is laparoscopy contraindicated for gallbladder cancer? A 10-year prospective cohort study. J Am Coll Surg. 221, 2015, pp. 847–853.

Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 98, 2008, pp. 485–9.

Mohammad Y. Zaidi, Ghassan K. Abou-Alfa, Cecilia G. Ethun, et al. Evaluation and management of incidental gallbladder cancer. Chin Clin Oncol. 2019 August ; 8(4): 37. 8, 2019, Vol. 4, 37.

Ethun CG, Postlewait LM, Le N, et al. Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium. JAMA Surg. 152, 2017, pp. 143–9.

Rathanaswamy S, Misra S, Kumar V, et al. Incidentally detected gallbladder cancer- the controversies and algorithmic approach to management. Indian J Surg . 74, 2012, pp. 248–54.

Mitin T, Enestvedt CK, Jemal A, et al. Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival. J Natl Cancer Inst. 2017, Vol. 109(7), pp. 1–9.

Creasy JM, Goldman DA, Dudeja V, et al. Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. J Am Coll Surg. 2017, Vol. 224(5), pp. 906-916.

Benson AB III, D’Angelica MI, Abbot DE, et al. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. [En ligne] 2 October 2018. https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary_blocks.pdf. .

Hoehn RS, Wima K, Ertel AE, et al. Adjuvant therapy for gallbladder cancer: an Analysis of the National Cancer Data Base. Journal of Gastrointestinal Surgery. 2015, Vol. 19, pp. 1794–1801.

Mantripragada KC, Hamid F, Shafqat H, et al. Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data base. J Natl Cancer Inst. 2017, Vol. 109.

TG, Kim. Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy. Radiat Oncol J. 2017, Vol. 35(4), pp. 359–67.

Tran Cao HS, Zhang Q, Sada YH, et al. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer Cytopathol . 2018, Vol. 124, pp. 74–83.

Verma V, Surkar SM, Brooks ED, et al. Chemoradiotherapy versus chemotherapy alone for unresected nonmetastatic gallbladder cancer: National practice patterns and outcomes. J Natl Compr Cancer Netw. 2018, Vol. 16(1):, pp. 59–65.